Article

American Health Assistance Foundation research grants available

The American Health Assistance Foundation (AHAF) is accepting proposals for research grants related to age-related macular degeneration (AMD) and glaucoma. The 501(c)3 nonprofit organization supports research leading to advances in the prevention and treatment of age-related diseases.

The American Health Assistance Foundation (AHAF) is accepting proposals for research grants related to age-related macular degeneration (AMD) and glaucoma. The 501(c)3 nonprofit organization supports research leading to advances in the prevention and treatment of age-related diseases.

In the area of AMD research, the duration and value of standard awards is $100,000 over 2 years. Letters of intent must be received by July 11; full applications are due Oct. 18.

In the area of national glaucoma research, the duration and value of such standard awards is $90,000 over 2 years. Full applications are due Nov. 16.

All research proposals are evaluated on the basis of scientific merit and their relevance to the cause, prevention, and treatment of diseases specified in the programs. Submitted proposals are subject to peer review by a qualified scientific review committee consisting of academic and clinical researchers from within the focus disease field.

Support is available to U.S. and international researchers pursuing innovative research leading to greater understanding of and therapeutic options for the treatment of these diseases.

AHAF does not provide support for large equipment purchases, construction or building expenses, or institutional overhead costs. For application instructions and more information, contact AHAF by phone at 301/948-3244 or online at www.ahaf.org.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.